EKF Diagnostics Holdings PLC - ESG Rating & Company Profile powered by AI
Detailed Sustainability assessment of EKF Diagnostics Holdings PLC are accessed by signing up for free. Jump to the bottom of the page for potential risks for EKF Diagnostics Holdings PLC based on industry, location and marketcap. This webpage contains a zero-cost E,S&G analysis for EKF Diagnostics Holdings PLC.
EKF Diagnostics Holdings PLC in the Advanced Medical Equipment & Technology industry gained a UN SDG ESG Transparency Score of 2.6; made up of an environmental score of 3.2, social score of 1.3 and governance score of 3.2.
2.6
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Calmark Sweden AB | 8.0 | High |
1 | CHC Healthcare Group | 8.0 | High |
... | ... | ... | |
191 | USA Equities Corp | 2.7 | Medium |
191 | Zenicor Medical Systems AB | 2.7 | Medium |
198 | EKF Diagnostics Holdings PLC | 2.6 | Medium |
198 | Itamar Medical Ltd | 2.6 | Medium |
198 | Medeon Biodesign Inc | 2.6 | Medium |
... | ... | ... | |
260 | Zhuhai Hokai Medical Instruments Co Ltd | 0.0 | Low |
260 | Zynex Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does EKF Diagnostics Holdings PLC have an accelerator or VC vehicle to help deliver innovation?
Does EKF Diagnostics Holdings PLC disclose current and historical energy intensity?
Does EKF Diagnostics Holdings PLC report the average age of the workforce?
Does EKF Diagnostics Holdings PLC reference operational or capital allocation in relation to climate change?
Does EKF Diagnostics Holdings PLC disclose its ethnicity pay gap?
Does EKF Diagnostics Holdings PLC disclose cybersecurity risks?
Does EKF Diagnostics Holdings PLC offer flexible work?
Does EKF Diagnostics Holdings PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does EKF Diagnostics Holdings PLC disclose the number of employees in R&D functions?
Does EKF Diagnostics Holdings PLC conduct supply chain audits?
Does EKF Diagnostics Holdings PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does EKF Diagnostics Holdings PLC conduct 360 degree staff reviews?
Does EKF Diagnostics Holdings PLC disclose the individual responsible for D&I?
Does EKF Diagnostics Holdings PLC disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does EKF Diagnostics Holdings PLC disclose current and / or historical scope 2 emissions?
Does EKF Diagnostics Holdings PLC disclose water use targets?
Does EKF Diagnostics Holdings PLC have careers partnerships with academic institutions?
Did EKF Diagnostics Holdings PLC have a product recall in the last two years?
Does EKF Diagnostics Holdings PLC disclose incidents of discrimination?
Does EKF Diagnostics Holdings PLC allow for Work Councils/Collective Agreements to be formed?
Has EKF Diagnostics Holdings PLC issued a profit warning in the past 24 months?
Does EKF Diagnostics Holdings PLC disclose parental leave metrics?
Does EKF Diagnostics Holdings PLC disclose climate scenario or pathway analysis?
Does EKF Diagnostics Holdings PLC disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does EKF Diagnostics Holdings PLC disclose the pay ratio of women to men?
Does EKF Diagnostics Holdings PLC support suppliers with sustainability related research and development?
Does EKF Diagnostics Holdings PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does EKF Diagnostics Holdings PLC reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is EKF Diagnostics Holdings PLC involved in embryonic stem cell research?
Does EKF Diagnostics Holdings PLC disclose GHG and Air Emissions intensity?
Does EKF Diagnostics Holdings PLC disclose its waste policy?
Does EKF Diagnostics Holdings PLC report according to TCFD requirements?
Does EKF Diagnostics Holdings PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does EKF Diagnostics Holdings PLC disclose energy use targets?
Does EKF Diagnostics Holdings PLC disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does EKF Diagnostics Holdings PLC have a policy relating to cyber security?
Have a different question?
Potential Risks for EKF Diagnostics Holdings PLC
These potential risks are based on the size, segment and geographies of the company.
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. The company also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes; and STAT-Site M Beta-hydroxybutyrate analyzer. In addition, it offers Creamatocrit Plus, an analyzer for detecting the lipid concentration and calorific density in mothers' milk; QuPID and True20 pregnancy tests; and Lactate Scout 4, a lactate analyzer. Further, the company provides clinical chemical analyzers, such as Beta-hydroxybutyrate for monitoring ketosis; Glycated Albumin; Glycated Serum Protein; Nitro-tab Ketone tablets; and Procalcitonin marker for bacterial infection and sepsis, as well as reagents, calibrators, standards, and controls. Additionally, it offers RaPET Serology immunoassay kits; QuStick Strep A for Strep A infection treatment; Altair 240, a chemistry analyzer; Excel, a semi-automated chemistry analyzer; Micro 12, a micro centrifuge for clinical, molecular, and bacteriological applications; Hema-Screen Serology, an analyzer dependent for early detection of colorectal cancer; Uri-Trak 120 urine analyzer; and kits and other services related to COVID-19, as well as contract manufacturing solutions to third-party businesses and laboratory services. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.